Zealand Pharma CEO on new FDA hurdle: “Insanely annoying situation”

The timing of the examination of dasiglucagon has actually been unfortunate for Zealand Pharma, which currently needs to delay obtaining the medicine to individuals by a couple of even more months.

发布者:BY CHRISTIAN BUNDGAARD,转转请注明出处:https://robotalks.cn/zealand-pharma-ceo-on-new-fda-hurdle-insanely-annoying-situation/

(0)
上一篇 10 10 月, 2024 9:17 上午
下一篇 10 10 月, 2024 9:17 上午

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。